Assessment of pancreatic exocrine insufficiency and pancreatic enzyme dose-response using the 13C-Mixed triglyceride breath test

Mathias Ellgaard Cook; Dean Campbell; Marianne Køhler; Tina Okdahl; J. Enrique Domínguez‐Muñoz; J-Matthias Löhr; Miroslav Vujasinović; Jutta Keller; Péter Hegyi; Søren Schou Olesen; Asbjørn Mohr Drewes

doi:10.6084/m9.figshare.31228948

Assessment of pancreatic exocrine insufficiency and pancreatic enzyme dose-response using the 13C-Mixed triglyceride breath test

Figshare 2026 Open access

Read full text

Authors: Mathias Ellgaard Cook, Dean Campbell, Marianne Køhler, Tina Okdahl, J. Enrique Domínguez‐Muñoz, J-Matthias Löhr, Miroslav Vujasinović, Jutta Keller, Péter Hegyi, Søren Schou Olesen, Asbjørn Mohr Drewes

DOI: 10.6084/m9.figshare.31228948

Cited by: 0

Abstract

Faecal elastase-1 testing is the most commonly used method for diagnosing pancreatic exocrine insufficiency (PEI), but has poor diagnostic precision and cannot guide titration of pancreatic enzyme replacement therapy (PERT). An alternative is 13C-mixed triglyceride breath test. We investigated concordance between breath test and faecal elastase-1, and response to bicarbonate-buffered enzymes. In this prospective study, adults with faecal elastase

Fields of Study & Subjects

Pancreatitis Pathology and Treatment Clinical Nutrition and Gastroenterology Pancreatic and Hepatic Oncology Research

Publication details

Journal / source: Figshare
Publication date: 2 February 2026